These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7112588)

  • 1. Involvement of FAD-containing monooxygenase in cocaine-induced hepatotoxicity.
    Kloss MW; Cavagnaro J; Rosen GM; Rauckman EJ
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):88-93. PubMed ID: 7112588
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P-450 and FAD-monooxygenase mediated S- and N-oxygenations.
    Damani LA; Houdi AA
    Drug Metabol Drug Interact; 1988; 6(3-4):235-44. PubMed ID: 3078288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine-induced hepatotoxicity in mice.
    Evans MA; Harbison RD
    Toxicol Appl Pharmacol; 1978 Sep; 45(3):739-54. PubMed ID: 725929
    [No Abstract]   [Full Text] [Related]  

  • 4. N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase.
    Kloss MW; Rosen GM; Rauckman EJ
    Mol Pharmacol; 1983 Mar; 23(2):482-5. PubMed ID: 6835204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhibitors of the FAD-containing monooxygenase system from rat liver microsomes on monomethylhydrazine metabolism and activation to reactive metabolites.
    Díaz Gómez MI; Castro JA
    Arch Toxicol; 1986 May; 59(1):64-6. PubMed ID: 3741147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecificity in the oxidation of phorate and phorate sulphoxide by purified FAD-containing mono-oxygenase and cytochrome P-450 isozymes.
    Levi PE; Hodgson E
    Xenobiotica; 1988 Jan; 18(1):29-39. PubMed ID: 3354230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine-induced hepatotoxicity: lipid peroxidation as a possible mechanism.
    Teaf CM; Freeman RW; Harbison RD
    Drug Chem Toxicol; 1984; 7(4):383-96. PubMed ID: 6489192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes.
    el Amri HS; Fargetton X; Delatour P; Batt AM
    Xenobiotica; 1987 Oct; 17(10):1159-68. PubMed ID: 3424864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
    Sevrioukova I; Truan G; Peterson JA
    Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute cocaine-induced hepatotoxicity in DBA/2Ha male mice.
    Kloss MW; Rosen GM; Rauckman EJ
    Toxicol Appl Pharmacol; 1982 Aug; 65(1):75-83. PubMed ID: 7147258
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance of some phase II biotransformation pathways to hepatotoxins.
    Gregus Z; Watkins JB; Thompson TN; Klaassen CD
    J Pharmacol Exp Ther; 1982 Aug; 222(2):471-9. PubMed ID: 7097566
    [No Abstract]   [Full Text] [Related]  

  • 12. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.
    Pellinen P; Stenbäck F; Kojo A; Honkakoski P; Gelboin HV; Pasanen M
    Hepatology; 1996 Mar; 23(3):515-23. PubMed ID: 8617431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors.
    Pellinen P; Honkakoski P; Stenbäck F; Niemitz M; Alhava E; Pelkonen O; Lang MA; Pasanen M
    Eur J Pharmacol; 1994 Jan; 270(1):35-43. PubMed ID: 8157080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity.
    Bornheim LM
    Toxicol Appl Pharmacol; 1998 May; 150(1):158-65. PubMed ID: 9630465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse.
    Pellinen P; Stenbäck F; Raunio H; Pelkonen O; Pasanen M
    Eur J Pharmacol; 1994 Nov; 292(1):57-65. PubMed ID: 7867690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 dependent biotransformation: some recent developments. Introductory remarks: cytochromne P-450 mixed function oxygenases.
    Finlayson MJ; Bellward GD
    Proc West Pharmacol Soc; 1980; 23():1-2. PubMed ID: 7403109
    [No Abstract]   [Full Text] [Related]  

  • 17. Is thiobenzamide a specific substrate for the microsomal FAD-containing monooxygenase?
    Levi PE; Tynes RE; Sabourin PJ; Hodgson E
    Biochem Biophys Res Commun; 1982 Aug; 107(4):1314-8. PubMed ID: 7138540
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of benzoylmethylecgonine in cocaine-induced hepatotoxicity.
    Freeman RW; Harbison RD
    J Pharmacol Exp Ther; 1981 Aug; 218(2):558-67. PubMed ID: 7252855
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 20. On the domain structure of cytochrome P450 102 (BM-3): isolation and properties of a 45-kDa FAD/NADP domain.
    Black SD
    Biochem Biophys Res Commun; 1994 Aug; 203(1):162-8. PubMed ID: 8074651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.